DK0897725T3 - Therapi mod Staphylococcus aureus - Google Patents

Therapi mod Staphylococcus aureus

Info

Publication number
DK0897725T3
DK0897725T3 DK98306571T DK98306571T DK0897725T3 DK 0897725 T3 DK0897725 T3 DK 0897725T3 DK 98306571 T DK98306571 T DK 98306571T DK 98306571 T DK98306571 T DK 98306571T DK 0897725 T3 DK0897725 T3 DK 0897725T3
Authority
DK
Denmark
Prior art keywords
staphylococcus aureus
against staphylococcus
therapy against
strains
strain
Prior art date
Application number
DK98306571T
Other languages
English (en)
Inventor
Thalia Ioanna Nicas
David Albert Preston
Michael Lee Zeckel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0897725T3 publication Critical patent/DK0897725T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK98306571T 1997-08-22 1998-08-18 Therapi mod Staphylococcus aureus DK0897725T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5671297P 1997-08-22 1997-08-22

Publications (1)

Publication Number Publication Date
DK0897725T3 true DK0897725T3 (da) 2004-12-13

Family

ID=22006150

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98306571T DK0897725T3 (da) 1997-08-22 1998-08-18 Therapi mod Staphylococcus aureus

Country Status (23)

Country Link
US (1) US5994297A (da)
EP (1) EP0897725B1 (da)
JP (1) JP2001513573A (da)
KR (1) KR100589548B1 (da)
CN (1) CN1276728A (da)
AT (1) ATE278413T1 (da)
AU (1) AU747418B2 (da)
BR (1) BR9811917A (da)
CA (1) CA2301589A1 (da)
CZ (1) CZ299098B6 (da)
DE (1) DE69826795T2 (da)
DK (1) DK0897725T3 (da)
EA (1) EA002602B1 (da)
ES (1) ES2229454T3 (da)
HU (1) HU226593B1 (da)
ID (1) ID24908A (da)
IL (2) IL134597A0 (da)
NO (1) NO327042B1 (da)
NZ (1) NZ502762A (da)
PT (1) PT897725E (da)
TR (1) TR200000475T2 (da)
UA (1) UA59410C2 (da)
WO (1) WO1999010006A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3006038T (pt) * 2008-08-30 2024-08-23 The Medicines Co Doses únicas de oritavancina para tratamento ou prevenção de uma infeção bacteriana
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用
KR102237887B1 (ko) 2013-03-15 2021-04-07 멜린타 서브시디어리 코프. 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW457248B (en) * 1994-01-28 2001-10-01 Lilly Co Eli Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
KR100589548B1 (ko) 2006-06-15
PT897725E (pt) 2004-12-31
UA59410C2 (uk) 2003-09-15
BR9811917A (pt) 2000-08-15
IL134597A (en) 2007-09-20
EA002602B1 (ru) 2002-06-27
ES2229454T3 (es) 2005-04-16
EA200000250A1 (ru) 2000-08-28
HUP0002920A2 (hu) 2001-01-29
IL134597A0 (en) 2001-04-30
NZ502762A (en) 2001-10-26
US5994297A (en) 1999-11-30
AU8913798A (en) 1999-03-16
NO20000851D0 (no) 2000-02-21
EP0897725B1 (en) 2004-10-06
JP2001513573A (ja) 2001-09-04
EP0897725A2 (en) 1999-02-24
CZ299098B6 (cs) 2008-04-23
KR20010023108A (ko) 2001-03-26
HU226593B1 (en) 2009-04-28
EP0897725A3 (en) 2000-02-09
CZ2000619A3 (en) 2001-05-16
DE69826795T2 (de) 2005-10-06
NO327042B1 (no) 2009-04-06
DE69826795D1 (de) 2004-11-11
NO20000851L (no) 2000-02-21
HUP0002920A3 (en) 2001-12-28
CA2301589A1 (en) 1999-03-04
ATE278413T1 (de) 2004-10-15
TR200000475T2 (tr) 2000-08-21
ID24908A (id) 2000-08-31
CN1276728A (zh) 2000-12-13
AU747418B2 (en) 2002-05-16
WO1999010006A1 (en) 1999-03-04

Similar Documents

Publication Publication Date Title
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
ES2155601T3 (es) Compuestos de benzolactama sustituidos como antagonistas de la sustancia p.
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
HN2000000051A (es) Derivados heterociclicos utiles como agentes anticancerosos
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
BR9609281A (pt) Método para o controle de bactérias gram-positivas resistentes a antibióticos e tratamento de infecções
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
SE7611103L (sv) Forfarande for framstellning av 2-azetidinonforeningar
DE69634961D1 (de) Neue zyklische depsipeptid pf1022 derivate
DE69825128D1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
DE69928384D1 (de) Behandlung und nachweis von staphylokokkeninfektionen
FI924424A0 (fi) Hjaertskyddande tokoferolanaloger.
TNSN04035A1 (fr) Azithromycine en dose unique
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
ES2136457T3 (es) Dimeros unidos covalentemente de antibioticos glucopeptidicos.
EA200100700A1 (ru) Гены и белки и их применение
BRPI0317795B8 (pt) derivados de alfa-aminoamida úteis como agentes antienxaqueca
DK0897725T3 (da) Therapi mod Staphylococcus aureus
EP1066045A4 (en) Mammalian-derived peptides for the treatment of microbial infection
EA200500353A1 (ru) Производные линкомицина, обладающие антибактериальной активностью
MX9201357A (es) Procedimiento para la preparacion enzimatica de macrolactona.
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
SE9001111D0 (sv) Supportive use
BR9611520A (pt) Composto hemo-reguladores.